Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Cokmert, Suna; Demir, LÜTFİYE; Can, Alper; Akyol, Murat; Bayoglu, Ibrahim; Dirican, Ahmet; Kucukzeybek, Yuksel; Erten, Cigdem; Tarhan, Mustafa

Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Atıf İçin Kopyala

Cokmert S., Demir L., Can A., Akyol M., Bayoglu I. V., Dirican A., ...Daha Fazla

JOURNAL OF BUON, cilt.19, sa.1, ss.75-82, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 19 Sayı: 1
Basım Tarihi: 2014
Dergi Adı: JOURNAL OF BUON
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.75-82
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Purpose: Erythrocyte mean corpuscular volume (MCV) increase has been described in patients treated with capaecitabine. In this study, we sought to evaluate the potential association of the erythrocyte MCV increase with tumor response and survival in patients with metastatic colorectal cancer (mCRC) treated with capecitabine.